Multiclass Neurodegenerative Disease Classification on ADNI3 CN vs. EMCI vs. AD
68.65AccuracyDW-DGAT
Evaluation Results
| Method | Links | ||||
|---|---|---|---|---|---|
| DW-DGATValidation Protocol=Ten-fold cross-validation2026.01 | 68.65 | 66.18 | 66.79 | 83.09 | |
| ViT-smallValidation Protocol=Ten-fold cross-validation2026.01 | 64.03 | 46.71 | 59.62 | 73.35 | |
| ChebNetIIValidation Protocol=Ten-fold cross-validation2026.01 | 62.9 | 50.15 | 58.36 | 75.07 | |
| GATv2Validation Protocol=Ten-fold cross-validation2026.01 | 62.07 | 48.39 | 58.86 | 74.19 | |
| LG-GNNValidation Protocol=Ten-fold cross-validation2026.01 | 61.64 | 43.56 | 58.08 | 71.78 | |
| VGG-19-BNValidation Protocol=Ten-fold cross-validation2026.01 | 60.64 | 42.41 | 55.93 | 71.21 | |
| GCNValidation Protocol=Ten-fold cross-validation2026.01 | 59.41 | 41.29 | 53.5 | 70.64 | |
| BrainGNNValidation Protocol=Ten-fold cross-validation2026.01 | 56.9 | 44.15 | 53.76 | 72.08 | |
| MLPValidation Protocol=Ten-fold cross-validation2026.01 | 56.69 | 40.08 | 47.67 | 70.04 | |
| BrainNet-TValidation Protocol=Ten-fold cross-validation2026.01 | 56.47 | 40.86 | 54.04 | 70.43 | |
| RA-GCNValidation Protocol=Ten-fold cross-validation2026.01 | 55.07 | 37.02 | 44.12 | 68.51 | |
| ResNet-34Validation Protocol=Ten-fold cross-validation2026.01 | 54.42 | 40.56 | 49.03 | 70.28 | |
| BrainNetCNNValidation Protocol=Ten-fold cross-validation2026.01 | 53.66 | 38.13 | 50.95 | 69.07 | |
| MA-GCNNValidation Protocol=Ten-fold cross-validation2026.01 | 53.28 | 36.64 | 40.45 | 68.32 | |
| GCN-MHSAValidation Protocol=Ten-fold cross-validation2026.01 | 50.86 | 34.19 | 40.03 | 67.1 |